Search Results - "Mathiot, C C"

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial by Bidard, F.C., Huguet, F., Louvet, C., Mineur, L., Bouché, O., Chibaudel, B., Artru, P., Desseigne, F., Bachet, J.B., Mathiot, C., Pierga, J.Y., Hammel, P.

“…Pancreatic carcinoma is one of the leading causes of cancer-related mortality. At the time of diagnosis, 30% of patients present with a locally advanced…”
Get full text

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients by Pierga, J.-Y., Hajage, D., Bachelot, T., Delaloge, S., Brain, E., Campone, M., Diéras, V., Rolland, E., Mignot, L., Mathiot, C., Bidard, F.-C.

“…Circulating tumor cells (CTCs) are a prognostic marker in metastatic breast cancer, but comparisons with serum tumor markers (CA 15-3, carcinoembryonic antigen…”
Get full text

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer by Bidard, F.-C., Mathiot, C., Delaloge, S., Brain, E., Giachetti, S., de Cremoux, P., Marty, M., Pierga, J.-Y.

“…Circulation of cancer cells in the blood is a mandatory step for metastasis, but circulating tumor cells (CTC) have a low metastatic efficiency in preclinical…”
Get full text

Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients by Bradwell, A, Harding, S, Fourrier, N, Mathiot, C, Attal, M, Moreau, P, Harousseau, J-L, Avet-Loiseau, H

“…To determine whether isotype matched immunoglobulin (Ig; Ig′κ/Ig′λ) ratios had prognostic significance in patients with intact Ig multiple myeloma (MM). Novel…”
Get full text

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy by Bidard, F.-C., Mathiot, C., Degeorges, A., Etienne-Grimaldi, M.-C., Delva, R., Pivot, X., Veyret, C., Bergougnoux, L., de Cremoux, P., Milano, G., Pierga, J.-Y.

“…We investigated whether circulating tumor cells (CTCs) and circulating endothelial cells (CECs) predict clinical outcome of first-line chemotherapy combined…”
Get full text

Mutations in TP53 are exclusively associated with del(17p) in multiple myeloma by LODE, Laurence, EVEILLARD, Marion, GUILHOT, François, CAILLOT, Denis, MARIT, Gérald, MATHIOT, Claire, FACON, Thierry, ATTAL, Michel, HAROUSSEAU, Jean-Luc, MOREAU, Philippe, MINVIELLE, Stéphane, AVET-LOISEAU, Hervé, TRICHET, Valérie, SOUSSI, Thierry, WUILLEME, Soraya, RICHEBOURG, Steven, MAGRANGEAS, Florence, IFRAH, Norbert, CAMPION, Loic, TRAULLE, Catherine

“…Deletion of the 17p13 chromosomal region [del(17p)] is associated with a poor outcome in multiple myeloma. Most of the studies have targeted the TP53 gene for…”
Get full text

Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience by Avet-Loiseau, H, Roussel, M, Campion, L, Leleu, X, Marit, G, Jardel, H, Dib, M, Decaux, O, Lamy, T, Tiab, M, Cony-Makhoul, P, Banos, A, Lepeu, G, Lifermann, F, Macro, M, Kolb, B, Hulin, C, Caillot, D, Traulle, C, Mathiot, C, Royer, B

Get full text

Dengue emergence and adaptation to peridomestic mosquitoes by Moncayo, Abelardo C, Fernandez, Zoraida, Ortiz, Diana, Diallo, Mawlouth, Sall, Amadou, Hartman, Sammie, Davis, C Todd, Coffey, Lark, Mathiot, Christian C, Tesh, Robert B, Weaver, Scott C

“…Phylogenetic evidence suggests that endemic and epidemic dengue viruses (DENV), transmitted among humans by the anthropophilic mosquitoes Aedes aegypti and Ae…”
Get full text

Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells by Bidard, F.-C., Vincent-Salomon, A., Sigal-Zafrani, B., Diéras, V., Mathiot, C., Mignot, L., Thiery, J.-P., Sastre-Garau, X., Pierga, J.-Y.

“…At metastatic relapse, detection of circulating tumor cells (CTC) in peripheral blood is predictive of poor survival of breast cancer patients. Detection of…”
Get full text

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma by Fouquet, G., Pegourie, B., Macro, M., Petillon, M.O., Karlin, L., Caillot, D., Roussel, M., Arnulf, B., Mathiot, C., Marit, G., Kolb, B., Stoppa, A.M., Brechiniac, S., Richez, V., Rodon, P., Banos, A., Wetterwald, M., Garderet, L., Royer, B., Hulin, C., Benbouker, L., Decaux, O., Escoffre-Barbe, M., Fermand, J.P., Attal, M., Avet-Loiseau, H., Moreau, P., Facon, T., Leleu, X.

“…The IFM2009-02 trial studied pomalidomide (4 mg daily, 21/28 versus 28/28) and dexamethasone in very advanced relapsed or refractory multiple myeloma (RRMM)…”
Get full text

Circulating tumor cell detection and transcriptomic profiles in early breast cancer patients by Reyal, F., Valet, F., de Cremoux, P., Mathiot, C., Decraene, C., Asselain, B., Brain, E., Delaloge, S., Giacchetti, S., Marty, M., Pierga, J.Y., Bidard, F.C.

Get full text

Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials by MOREAU, P, ATTAL, M, WETTERWALD, M, MATHIOT, C, CAILLOT, D, BERTHOU, C, BENBOUBKERL, L, GARDERET, L, CHALETEIX, C, TRAULLA, C, FUZIBET, J. G, JAUBERT, J, GARBAN, F, LAMY, T, CASASSUS, P, DIB, M, KOLB, B, DORVAUX, V, GROSBOIS, B, YAKOUB-AGHA, I, HAROUSSEAU, J. L, AVET-LOISEAU, H, HULIN, C, FACON, T, MARIT, G, MICHALLET, M, DOYEN, C, LEYVRAZ, S, MOHTY, M

“…One hundred de novo multiple myeloma patients with t(4;14) treated with double intensive therapy according to IFM99 protocols were retrospectively analyzed…”
Get full text

Mosquito vectors of the 1998-1999 outbreak of Rift Valley Fever and other arboviruses (Bagaza, Sanar, Wesselsbron and West Nile) in Mauritania and Senegal by Diallo, M, Nabeth, P, Ba, K, Sall, A.A, Ba, Y, Mondo, M, Girault, L, Abdalahi, M.O, Mathiot, C

“…Following an outbreak of Rift Valley fever (RVF) in south-eastern Mauritania during 1998, entomological investigations were conducted for 2 years in the…”
Get full text

Stem cell collection in patients with de novo multiple myeloma treated with the combination of bortezomib and dexamethasone before autologous stem cell transplantation according to IFM 2005–01 trial by Moreau, P, Hulin, C, Marit, G, Caillot, D, Facon, T, Lenain, P, Berthou, C, Pégourié, B, Stoppa, A M, Casassus, P, Michallet, M, Benboubker, L, Maisonneuve, H, Doyen, C, Leyvraz, S, Mathiot, C, Avet-Loiseau, H, Attal, M, Harousseau, J L

Get full text

Rituximab in CD20 positive multiple myeloma by Moreau, P, Voillat, L, Benboukher, L, Mathiot, C, Dumontet, C, Robillard, N, Hérault, O, Garnache, F, Garand, R, Varoqueaux, N, Avet-Loiseau, H, Harousseau, J L, Bataille, R

Get full text

Production of matrix metalloproteinase-9 in early stage B-CLL: suppression by interferons by BAUVOIS, B, DUMONT, J, MATHIOT, C, KOLB, J-P

“…Besides vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), matrix metalloproteinases (MMPs) play critical roles in…”
Get full text

5021 POSTER DISCUSSION Multivariable Prognostic Model for Individual Survival Prediction of Metastatic Breast Cancer Patients Taking Into Account Circulating Tumour Cells (CTC) Count Before and During Chemotherapy by Bidard, F, Hajage, D, Bachelot, T, Delaloge, S, Brain, E, Campone, M, Dieras, V, Asselain, B, Mathiot, C, Pierga, J.Y

Get full text

5023 POSTER DISCUSSION Cyfra 21-1 Correlation With Circulating Tumour Cells (CTC) Detection and Patient Outcome in Metastatic Breast Cancer: Results of a Substudy of the Prospective IC 2004-06 Trial by Pierqa, J, Hajage, D, Bachelot, T, Delaloge, S, Brain, E, Campone, M, Mathiot, C, Mignot, L, Bidard, F.C

Get full text

Epidemiological and virological influenza survey in Dakar, Senegal: 1996-1998 by Dosseh, A, Ndiaye, K, Spiegel, A, Sagna, M, Mathiot, C

“…An influenza survey was conducted in seven sentinel sites in Dakar, Senegal from June 1996 to December 1998. Throat or nasal swab cultures were randomly…”
Get more information

Bortezomib/dexamethasone versus VAD as induction prior to autologous stem cell transplantion (ASCT) in previously untreated multiple myeloma (MM): Updated data from IFM 2005/01 trial by Harousseau, J. L., Mathiot, C., Attal, M., Marit, G., Caillot, D., Hullin, C., Facon, T., Webb, I., Avet-Loiseau, H., Moreau, P.

“…Abstract only…”
Get full text